FindTrial
Sign In

Method of prescribing ketamine and midazolam and how safe it is when it is used together in adult burn patients

Prescription pattern and safety of ketamine-midazolam combination in adult burn patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/096032
Enrollment
100
Registered
2025-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: X088- Exposure to other specified smoke,fire and flames

Interventions

Intervention1: Ketamine + Midazolam: Combination of ketamine and midazolam intended for sedoanalgesia of burn patients Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervent

Sponsors

Manipal Academy Of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients above or equal to 18 years with burn injuries

Exclusion criteria

Exclusion criteria: Patients Not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Assesment of change in pain scores at random time points Timepoint: random points from time of administration to half life ( ketamine half life 2-4 hours, Midazolam half life 1.5-2.5 hours)—

Secondary

MeasureTime frame
• Assessment of sedation level • Requirement for rescue medication • Presence of ADRsTimepoint: random points from time of administration to half life ( ketamine half life 2-4 hours, Midazolam half life 1.5-2.5 hours)—

Countries

India

Contacts

Public ContactDr Rajesh V

Kasturba Medical College

joseph.plastic@manipal.edu9995783582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026